APOE and atherosclerosis: At 45 weeks, ApoE−/−/IL-4−/− mice had a significant decrease of 58% and 64% of atherosclerosis located in the aortic arch compared to ApoE−/− and ApoE−/−/IL-12−/− mice, respectively.